Humana expands nuclear medicine coverage
Humana will now cover PET/CT for cardiac/neurologic indications and SPECT/C...Read more on AuntMinnie.comRelated Reading: Molecular imaging saw wins, losses over past year Attralus touts amyloid imaging research at SNMMI 2021 SNMMI releases slate of officers for 2021-2022 term SNMMI's Image of the Year shows COVID-19's long-term neuro effects Humana partially reverses PET/CT policy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2021 Category: Radiology Source Type: news

Why remote radiology board exams are here to stay
Ready or not, radiology residents and their educators are getting a crash cours...Read more on AuntMinnie.comRelated Reading: ABR will host all 2022 exams remotely ABR mulls over change to residency leave policy Radiography, nuclear medicine enrollment down in 2020 Radiology trainees decry moving Core Exam to 2021 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2021 Category: Radiology Source Type: news

NorthStar appoints new senior VP, COO
NorthStar Medical Radioisotopes appointed Frank Scholz, PhD, as its new senio...Read more on AuntMinnie.comRelated Reading: NorthStar partners with Clarity, Monopar NorthStar, IBA expand Tc-99m collaboration NorthStar reorganizes to advance nuclear medicine agents NorthStar gets FDA nod to produce Mo-99 from cMo-98 NorthStar promotes Estrum to executive vice president (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 21, 2021 Category: Radiology Source Type: news

SNMMI Image of the Year: PET imaging measures cognitive impairment in COVID-19 patients
(Society of Nuclear Medicine and Molecular Imaging) The effects of COVID-19 on the brain can be accurately measured with positron emission tomography (PET), according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting. The detailed depiction of areas of cognitive impairment, neurological symptoms and comparison of impairment over a six-month time frame has been selected as SNMMI's 2021 Image of the Year. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 16, 2021 Category: Infectious Diseases Source Type: news

SNMMI releases slate of officers for 2021-2022 term
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released it...Read more on AuntMinnie.comRelated Reading: SNMMI pushes for coverage of PET tracers for Aduhelm use SNMMI offers letter to contest SPECT/CT denials SNMMI urges Congress to continue support for medical research Humana partially reverses PET/CT policy SNMMI lands 'Hangover' star Jeong as guest speaker (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 15, 2021 Category: Radiology Source Type: news

PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
This study was presented at the SNMMI 2021 Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news

Novel radiopharmaceutical tracks 'master switch' protein responsible for cancer growth
This study was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news

Steven M. Larson, M.D., receives SNMMI 2021 Paul C. Aebersold Award
(Society of Nuclear Medicine and Molecular Imaging) Steven M. Larson, M.D., has been named the 2021 recipient of the prestigious Paul C. Aebersold Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2021 Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news

New theranostic approach joins radiopharmaceuticals and nanoparticles to kill cancer cells
(Society of Nuclear Medicine and Molecular Imaging) Researchers have successfully developed a novel cancer treatment approach that utilizes Cerenkov radiation energy to target and destroy cancer cells more effectively. The approach uses light from decaying radiopharmaceuticals, known as Cerenkov luminescence, as an energy source to activate semiconducting polymer nanoparticles that kill cancer cells. This research was presented at the Society of Nuclear Medicine and Molecular Imaging's 2021 Virtual Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

New super-resolution technique allows for more detailed brain imaging
(Society of Nuclear Medicine and Molecular Imaging) A new imaging technique has the potential to detect neurological disorders--such as Alzheimer's disease--at their earliest stages, enabling physicians to diagnose and treat patients more quickly. Termed super-resolution, the imaging methodology combines position emission tomography (PET) with an external motion tracking device to create highly detailed images of the brain. This research was presented at the Society of Nuclear Medicine and Molecular Imaging's 2021 Virtual Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2021 Category: International Medicine & Public Health Source Type: news

Are ventilation scans needed in pulmonary embolism assessments?
Are ventilation nuclear medicine lung scans really needed in cases of suspecte...Read more on AuntMinnie.comRelated Reading: SNMMI pushes for coverage of PET tracers for Aduhelm use SNMMI issues new guidelines on V/Q scans SNMMI urges fast-track review of Technegas for V/Q scans SNMMI updates ventilation study guidance SNMMI 2020: How nuclear medicine handled COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 12, 2021 Category: Radiology Source Type: news

Radiotracer effective for detection and assessment of lung fibrosis
(Society of Nuclear Medicine and Molecular Imaging) Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. By binding to activated fibroblasts present in affected lungs, FAPI-PET allows for direct imaging of the disease process. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2021 Category: International Medicine & Public Health Source Type: news

SNMMI pushes for coverage of PET tracers for Aduhelm use
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced it wil...Read more on AuntMinnie.comRelated Reading: PET radiotracer tweaked for greater precision in AD detection FDA approves Alzheimer's treatment under accelerated pathway 'Early frame' PET may reduce cost and burden in Alzheimer's disease New PET tracer may show early pathology of Alzheimer's disease Blue Earth eyes new uses for fluciclovine F-18 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 11, 2021 Category: Radiology Source Type: news

Researchers tout ovarian cancer alpha therapy at SNMMI 2021
New research in mice presented June 11 at the Society of Nuclear Medicine an...Read more on AuntMinnie.comRelated Reading: Niowave starts isotope production Niowave begins Mo-99 production in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 11, 2021 Category: Radiology Source Type: news

Deep learning with SPECT accurately predicts major adverse cardiac events
(Society of Nuclear Medicine and Molecular Imaging) An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac events more accurately than current standard imaging protocols, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. Utilizing data from a registry of more than 20,000 patients, researchers developed a novel deep learning network that has the potential to provide patients with an individualized prediction of their annualized risk for adverse events. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2021 Category: International Medicine & Public Health Source Type: news

Promising ovarian cancer treatment proves effective and efficient
(Society of Nuclear Medicine and Molecular Imaging) Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant to traditional therapies, the new radiopharmaceutical can be produced in 25 minutes at low cost, which leads to better efficiency compared with alternative methods. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2021 Category: International Medicine & Public Health Source Type: news

SNMMI to lobby for coverage of PET tracers for Aduhelm use
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced it wil...Read more on AuntMinnie.comRelated Reading: PET radiotracer tweaked for greater precision in AD detection FDA approves Alzheimer's treatment under accelerated pathway 'Early frame' PET may reduce cost and burden in Alzheimer's disease New PET tracer may show early pathology of Alzheimer's disease Blue Earth eyes new uses for fluciclovine F-18 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 10, 2021 Category: Radiology Source Type: news

SNMMI offers letter to contest SPECT/CT denials
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has publishe...Read more on AuntMinnie.comRelated Reading: SNMMI urges Congress to continue support for medical research Humana partially reverses PET/CT policy SNMMI lands 'Hangover' star Jeong as guest speaker Reps. ask CMS to change policy on radiopharmaceuticals SNMMI provides update on COVID-19 vaccine and PET/CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 3, 2021 Category: Radiology Source Type: news

SNMMI Virtual Annual Meeting to take place June 11-15, 2021
(Society of Nuclear Medicine and Molecular Imaging) The SNMMI Virtual Annual Meeting will convene more than 6,000 attendees to share research in the field of nuclear medicine -- developing new ways to diagnose and treat disease effectively and safely, with minimal side effects and exceptional results for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 28, 2021 Category: Cancer & Oncology Source Type: news

COVID-19's impact on radiologist careers differs by gender
COVID-19 has had different effects on the careers of radiologists dependin...Read more on AuntMinnie.comRelated Reading: Women and minorities underrepresented in nuclear medicine COVID-19 has had dramatic effect on breast imaging How has COVID-19 affected publishing for female radiologists? Medical practices with fewer women have bigger wage gaps Is there gender bias in videoconferencing? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 26, 2021 Category: Radiology Source Type: news

NorthStar partners with Clarity, Monopar
NorthStar Medical Radioisotopes and radiopharmaceutical firm Clarity Pharmaceutical...Read more on AuntMinnie.comRelated Reading: NorthStar, IBA expand Tc-99m collaboration NorthStar reorganizes to advance nuclear medicine agents NorthStar gets FDA nod to produce Mo-99 from cMo-98 NorthStar promotes Estrum to executive vice president NorthStar, Monopar team up to create COVID-19 therapies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 25, 2021 Category: Radiology Source Type: news

SNMMI urges Congress to continue support for medical research
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is urging Congres...Read more on AuntMinnie.comRelated Reading: SNMMI lands 'Hangover' star Jeong as guest speaker SNMMI provides update on COVID-19 vaccine and PET/CT SNMMI issues new guidelines on V/Q scans CMS ends noncoverage of PET infection and inflammation SNMMI confirms Medicare reimbursement error for Cerianna (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 24, 2021 Category: Radiology Source Type: news

Government mulling roping in 3-4 more firms to ramp up DRDO COVID-19 drug production
2-DG has been developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS), in collaboration with Dr Reddy's Laboratories, Hyderabad. Clinical trial results have shown that this molecule helps in the faster recovery of hospitalized patients and reduces supplemental oxygen dependence. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 21, 2021 Category: Pharmaceuticals Source Type: news

Radiology trainees seek help online first when reading images
Where do radiology trainees go for help when they are on call in a high-stake...Read more on AuntMinnie.comRelated Reading: Burnout looms larger for third-year residents Women and minorities underrepresented in nuclear medicine Top 10 tips for newly graduated radiologists Dutch look for answers to fix nuclear medicine training Survey finds many radiologists still fear being replaced by AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 19, 2021 Category: Radiology Source Type: news

DRDO developed 2-DG drug could be game-changer: Karnataka Health Minister Dr K Sudhakar
The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2021 Category: Pharmaceuticals Source Type: news

DCGI approves anti-COVID drug developed by DRDO for emergency use
According to Defence Research and Development Organisation (DRDO) statement, an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO in collaboration with Dr Reddy's Laboratories, Hyderabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 8, 2021 Category: Pharmaceuticals Source Type: news

With new treatments, PET imaging adds valuable information to brain metastasis monitoring
(Society of Nuclear Medicine and Molecular Imaging) For patients with brain metastases, amino acid positron emission tomography (PET) can provide valuable information about the effectiveness of state-of-the-art treatments. When treatment monitoring with contrast-enhanced magnetic resonance imaging (MRI) is unclear, adding 18F-FET PET can help to accurately diagnose recurring brain metastases and reliably assess patient response. This research was published in The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 4, 2021 Category: International Medicine & Public Health Source Type: news

People of color more likely to participate in cancer trials
People of color, those with a higher income, and younger individuals are mor...Read more on AuntMinnie.comRelated Reading: Women and minorities underrepresented in nuclear medicine Women of color still face barriers in breast cancer treatment Race, income, education affect women's access to DBT screening Study finds racial disparities in pediatric ED imaging Black women die more frequently from breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 30, 2021 Category: Radiology Source Type: news

Women and minorities underrepresented in nuclear medicine
Women and members of racial and ethnic groups are significantly underrepresente...Read more on AuntMinnie.comRelated Reading: Dutch look for answers to fix nuclear medicine training Lack of Medicare CTC coverage affects people of color Are lesbian, bisexual women less likely to get mammograms? Racial bias affects radiology residency letters Demographic factors limit access to CT lung screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 29, 2021 Category: Radiology Source Type: news

Humana partially reverses PET/CT policy
Humana will begin covering PET/CT imaging for gastric and esophageal oncologi...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT may increase survival in SCC patients FDG-PET/CT effective for staging in new breast cancer SNMMI provides update on COVID-19 vaccine and PET/CT PET/CT shows link between stress and fatal heart condition Nuclear medicine groups oppose Humana PET/CT policy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2021 Category: Radiology Source Type: news

SNMMI lands 'Hangover' star Jeong as guest speaker
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announce...Read more on AuntMinnie.comRelated Reading: Reps. ask CMS to change policy on radiopharmaceuticals SNMMI provides update on COVID-19 vaccine and PET/CT SNMMI issues new guidelines on V/Q scans CMS ends noncoverage of PET infection and inflammation SNMMI, Zionexa call out CMS for reimbursement error (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2021 Category: Radiology Source Type: news

Nuclear Medicine Prepares for Greater 68Ga Demand Nuclear Medicine Prepares for Greater 68Ga Demand
The recent FDA approval of Gallium-68 prostate-specific membrane antigen has resulted in unprecedented demand and a ramping up of its production and associated components by several companies.Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2021 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

SNMMI provides update on COVID-19 vaccine and PET/CT
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has updated it...Read more on AuntMinnie.comRelated Reading: SNMMI issues new guidelines on V/Q scans FDG-PET/CT shows COVID-19 vaccine uptake PET/CT guidance offers valuable approach to lung biopsies SNMMI 2020: PSMA-PET/CT changes prostate cancer management SNMMI 2020: How nuclear medicine handled COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2021 Category: Radiology Source Type: news

Lantheus buys rights to PET oncology imaging agent
Lantheus Medical Imaging parent company Lantheus Holdings said it has purchase...Read more on AuntMinnie.comRelated Reading: Lantheus experiences net loss in Q4, full fiscal year Lantheus touts ASCO GU talks with PSMA agent Lantheus submits drug master file for imaging biomarker Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 30, 2021 Category: Radiology Source Type: news

Dutch look for answers to fix nuclear medicine training
Is there a way to stem the declining numbers of residents pursuing specialtie...Read more on AuntMinnie.comRelated Reading: Survey finds many radiologists still fear being replaced by AI SNMMI 2020: Medical students key to the specialty's future ABNM, ABR scrap plan to revamp nuclear medicine training Proposal would dissolve ABNM, fold functions into ABR Nuclear medicine residents see 'dismal' job market (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2021 Category: Radiology Source Type: news

New treatment proves more effective and less toxic for neuroendocrine tumor patients
(Society of Nuclear Medicine and Molecular Imaging) A new treatment for late-stage neuroendocrine tumors (NETs) has been found to be more effective and have fewer side effects than the current standard of care, according to research published in the March issue of The Journal of Nuclear Medicine. The novel peptide receptor radionuclide therapy holds promise to reduce mortality among NET patients and decrease the financial burden of their continual treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2021 Category: Cancer & Oncology Source Type: news

Immuno-PET can give physicians early insight into tumor response to targeted therapy
(Society of Nuclear Medicine and Molecular Imaging) Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor's response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer. The new research was published in the March issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2021 Category: International Medicine & Public Health Source Type: news

BWXT, GMS form joint venture for Asia-Pacific
BWX Technologies (BWXT) subsidiary and medical isotope and radiopharmaceutica...Read more on AuntMinnie.comRelated Reading: BWXT appoints new president for BWXT ITG Canada FDA approves BWXT's radiopharmaceutical BWXT completes acquisition of Nordion business BWXT selects Mo-99 irradiation provider GMS to divest Chinese nuclear medicine business (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 9, 2021 Category: Radiology Source Type: news

NorthStar, IBA expand Tc-99m collaboration
NorthStar Medical Radioisotopes and proton therapy developer Ion Beam Application...Read more on AuntMinnie.comRelated Reading: NorthStar reorganizes to advance nuclear medicine agents IBA adds CBCT to 2 proton therapy centers NorthStar promotes Estrum to executive vice president IBA receives 1st payment from Chinese licensing deal IBA secures large proton therapy contract in China NorthStar, Monopar team up to create COVID-19 therapies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 8, 2021 Category: Radiology Source Type: news

Nuclear medicine
(Source: ScienceNOW)
Source: ScienceNOW - March 4, 2021 Category: Science Authors: Normile, D. Tags: Asia/Pacific News, Medicine, Diseases, Scientific Community Feature Source Type: news

Who Gets Pott ’ s Puffy Tumor?
Discussion Pott’s puffy tumor (PPT) was first described by Sir Percivall Pott in 1775 and who also described other orthopaedic and oncological diseases subsequently named for him. “It is a subperiosteal abscess of the anterior wall of the frontal sinus associated with underlying frontal osteomyelitis.” The tender edema and swelling of the forehead is the sign of PPT. Associated fever, headache, and rhinorrhea along with similar problems such as postnasal drip or nasal congestion are common. Associated ophthalmological problems include peri-orbital or eyelid edema and/or preseptal cellulitis. Ptosis and di...
Source: PediatricEducation.org - March 1, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Lantheus experiences net loss in Q4, full fiscal year
A slight increase in revenue for the fourth quarter wasn't enough to offse...Read more on AuntMinnie.comRelated Reading: Lantheus touts ASCO GU talks with PSMA agent Lantheus submits drug master file for imaging biomarker Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 27, 2021 Category: Radiology Source Type: news

SNMMI confirms Medicare reimbursement error for Cerianna
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) said that th...Read more on AuntMinnie.comRelated Reading: SNMMI, Zionexa call out CMS for reimbursement error SNMMI to hold 2021 annual meeting virtually SNMMI urges fast-track review of Technegas for V/Q scans SNMMI: Imagers should get COVID-19 shots early Imaging agent for breast cancer PET gets FDA nod (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 24, 2021 Category: Radiology Source Type: news

Molecular imaging determines effectiveness of novel metastatic breast cancer treatment
(Society of Nuclear Medicine and Molecular Imaging) Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news

RadQual signs distribution deal with LEA
Radioisotope manufacturer International Isotope's RadQual nuclear medicine quality-contro...Read more on AuntMinnie.comRelated Reading: International Isotopes' Q1 revenue declines International Isotopes revenues slide in 2019 International Isotopes receives FDA nod for I-131 Revenue slips at International Isotopes in Q3 International Isotopes posts Q1 decreases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 9, 2021 Category: Radiology Source Type: news

SNMMI, Zionexa call out CMS for reimbursement error
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is teaming u...Read more on AuntMinnie.comRelated Reading: SNMMI urges fast-track review of Technegas for V/Q scans SNMMI: Imagers should get COVID-19 shots early SNMMI celebrates 60th anniversary with special issue New x-ray systems mark Siemens exhibit at RSNA 2020 Imaging agent for breast cancer PET gets FDA nod (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2021 Category: Radiology Source Type: news

Joint radionuclide therapy-immunotherapy approach effective in prostate cancer model
(Society of Nuclear Medicine and Molecular Imaging) A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine. The results of the murine study indicate that radionuclide therapy promotes prostate cancer immunogenicity, provoking a cellular response that makes the tumors more receptive to immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2021 Category: Cancer & Oncology Source Type: news

Lantheus touts ASCO GU talks with PSMA agent
Lantheus Holdings, parent company of Lantheus Medical Imaging, along with it...Read more on AuntMinnie.comRelated Reading: Lantheus submits drug master file for imaging biomarker Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software Sofie, Lantheus ink deal for prostate cancer imaging agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2021 Category: Radiology Source Type: news

SNMMI to hold 2021 annual meeting virtually
For the second year in a row, the Society of Nuclear Medicine and Molecula...Read more on AuntMinnie.comRelated Reading: SNMMI urges fast-track review of Technegas for V/Q scans SNMMI: Imagers should get COVID-19 shots early SNMMI celebrates 60th anniversary with special issue Nuclear medicine groups oppose Humana PET/CT policy SNNMI joins doc groups criticizing 'COVID-19 inflation' theory (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 2, 2021 Category: Radiology Source Type: news

BARC evolves design for 1st PPP research reactor for nuclear medicine
The state-run the Department of Atomic Energy (DAE) will share the technology of production of a variety of nuclear medicines and the private entities will get exclusive rights to process and market the isotopes produced in the research reactor, in lieu of investing in the reactor and processing facilities, an official statement said. (Source: The Economic Times)
Source: The Economic Times - January 29, 2021 Category: Consumer Health News Source Type: news